Nanosphere (NSPH +7.2%) pops today after Jefferies analyst Brandon Couillard assumes coverage with a Buy and raises his price target on the shares from $3.50 to $5.50. Couillard notes that NSPH's proprietary gram-positive blood stream infection test should drive significant new system placements and revenue growth over the next several years.
Nanosphere (NSPH +7.2%) pops today after Jefferies analyst Brandon Couillard assumes coverage...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs